Feedback / Questions
Lonsurf (trifluridine/tipiracil) - Servier, Otsuka
Oncoral (irinotecan oral) - Ascelia
Lipoxal (oxaliplatin) - Regulon
Stivarga (regorafenib) - Bayer
Braftovi (encorafenib) - Ono Pharma, Pierre Fabre, Pfizer
https://www.targetedonc.com/investigator-perspectives/sequencing-metastatic-crc/mcrc-secondline-treatment-decisions
Mar 20, 2020
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next